Calendar Unity Biotechnology, Inc.

Equities

UBX

US91381U2006

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
1.5 USD +1.35% Intraday chart for Unity Biotechnology, Inc. 0.00% -22.28%

Chart calendar Unity Biotechnology, Inc.

ad297a1ae8bfcc2.bqGq-w1d-MOnSkP8XPSmjJacxTTYVz94QzrH3kI1FKo.D9eflWgft63FBwG5F5bi5tOujQShZGAPN0K9t3JlIe8K88uVdQjNq_AYdw~cc3438a9cbee4f2c59761f61585ff15a

Upcoming events on Unity Biotechnology, Inc.

2024-05-06 11:30 am Association for Research in Vision and Ophthalmology Meeting - Poster No:B0103
2024-05-06 Q1 2024 Earnings Release (Projected)
2024-05-08 05:15 pm Association for Research in Vision and Ophthalmology Meeting - Poster No:B0391
2024-08-05 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-11 Q4 2024 Earnings Release (Projected)

Past events on Unity Biotechnology, Inc.

2024-04-15 07:00 am Q4 2023 Earnings Release
2023-11-13 09:05 pm Q3 2023 Earnings Release
2023-09-11 07:00 am H.C. Wainwright Global Investment Conference
2023-08-16 12:00 pm H.C. Wainwright Ophthalmology Virtual Conference - Panel
2023-08-16 07:00 am H.C. Wainwright Ophthalmology Virtual Conference
2023-08-08 04:05 pm Q2 2023 Earnings Release
2023-06-23 12:00 pm Annual General Meeting
2023-05-09 04:05 pm Q1 2023 Earnings Release
2023-04-24 08:00 am UBX1325 Phase 2 Clinical Trial Results Call
2023-03-27 08:00 am UBX1325 Phase 2 Study Results Call
2023-03-15 04:05 pm Q4 2022 Earnings Release
2023-03-07 09:50 am Cowen Health Care Conference
2023-02-15 11:20 am SVB Securities Global Biopharma Conference
2023-02-14 10:00 am ENVISION Phase 2 Study Results Call
2022-11-08 Q3 2022 Earnings Release (Projected)
2022-11-01 08:00 am UBX1325 Phase 2 Study Resluts Call
2022-10-17 Extraordinary Shareholders Meeting
2022-10-12 08:00 am Analyst & Investor Day
2022-09-12 04:00 pm H.C. Wainwright Global Investment Conference
2022-09-05 Citi BioPharma Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
4,78
0,00
-
0,24
0,23
3.96%
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
-87,0
-85,8
-1.42%
-90,5
-95,0
4.78%
-53,8
-60,3
10.84%
-55,4
-54,7
-1.25%
0,00
-39,8
-

-40,1

EBIT
Million USD
Released
Forecast
Spread
-89,7
-88,7
-1.08%
-93,9
-103
9.02%
-56,7
-65,9
14.05%
-57,6
-57,5
-0.18%
-44,7
-46,4
3.74%

-35,5

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-60,7
-71,4
14.99%
-59,9
-60,4
0.8%
-39,9
-50,1
20.47%

-41,2

Net income
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-60,7
-70,1
13.41%
-59,9
-60,6
1.05%
-39,9
-50,1
20.39%

-41,2

EPS
USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-10,9
-12,8
14.62%
-6,31
-2,90
-117.34%
-2,70
-3,43
21.17%

-2,42

Announcement Date11/03/2023/03/2115/03/2215/03/2315/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
4,78
0,00
-
0,00
0,00
-
0,24
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread

























-8,83


-9,28


-9,76


-10,3




EBIT
Million USD
Released
Forecast
Spread
-9,90
-19,8
50.06%
-18,3
-15,1
-20.97%
-12,3
-17,7
30.55%
-13,1
-13,1
-0.43%
-13,9
-13,9
0.1%
-10,7
-15,0
28.82%
-12,0
-12,0
-0.05%
-14,9
-12,7
-17.54%
-7,68
-10,7
28.4%

-9,38


-9,85


-10,3


-10,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-10,7
-21,4
50.04%
-18,9
-17,1
-10.69%
-13,1
-18,1
27.39%
-13,7
-14,0
2.12%
-14,2
-14,6
2.97%
-10,9
-15,6
30.21%
-12,2
-12,6
3.46%
-15,3
-13,0
-17.74%
-4,34
-11,8
63.1%

-9,58


-10,0


-10,5


-11,1

Net income
Million USD
Released
Forecast
Spread
-10,7
-20,1
46.8%
-18,9
-17,1
-10.69%
-13,1
-18,4
28.56%
-13,7
-13,9
1.05%
-14,2
-14,6
3.16%
-10,9
-15,6
30.21%
-12,2
-12,2
0.31%
-15,3
-13,0
-17.74%
-4,34
-11,8
63.1%

-9,58


-10,0


-10,5


-11,1

EPS
USD
Released
Forecast
Spread
-1,80
-3,60
50%
-2,80
-2,67
-5%
-1,90
-2,93
35.04%
-1,36
-1,07
-27.7%
-1,00
-1,03
3.23%
-0,76
-1,09
30.06%
-0,85
-0,85
0%
-1,05
-0,89
-17.98%
-0,28
-0,77
63.64%

-0,57


-0,59


-0,62


-0,64

Announcement Date15/03/2210/05/2212/08/2208/11/2215/03/2309/05/2308/08/2313/11/2315/04/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. UBX Stock
  4. Calendar Unity Biotechnology, Inc.